Patents by Inventor Massimo Baldacci

Massimo Baldacci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4794170
    Abstract: For the preparation of conjugates of adenine-9-beta-D-arabinofuranoside 5'monophosphate (ara-AMP) with lactosaminated human albumin (L-HSA) aqueous solutions of the two components to be conjugated are brought into contact in the presence of 1-ethyl-3-(dimethylaminopropyl)-carbodiimide, by adjusting the pH in the range from slightly acidic to alkaline and by carrying out the conjugate separation. The resulting conjugate, wherein the molar ratio, as determined through spectrophotometric route, between ara-AMP and L-HSA does vary between 5 and 20, remains soluble after lyophilization even at room temperature and shows biological activity at least equivalent to that of the conjugate as prepared according to the known art.
    Type: Grant
    Filed: December 11, 1985
    Date of Patent: December 27, 1988
    Assignee: Laboratori Baldacci SpA
    Inventors: Luigi Fiume, Corrado Busi, Alessandro Mattioli, Massimo Baldacci
  • Patent number: 4725672
    Abstract: A conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin is therapeutically more efficacious than the free drug in the treatment of chronical hepatitis induced from Virus B. For the preparation of the conjugate an aqueous solution of 9-(2-hydroxyethoxymethyl)-guanine in form of a derivative, particularly monophosphate, and an aqueous solution of lactosaminated human albumin are reacted in the presence of 1-ethyl-3-(dimethylaminopropyl)-carbodiimide, by adjusting the pH to the value of 7.5 and by maintaining the reaction mixture for 24 hours under stirring and in the dark.
    Type: Grant
    Filed: October 21, 1986
    Date of Patent: February 16, 1988
    Assignee: Laboratori Baldacci S.p.A.
    Inventors: Massimo Baldacci, Luigi Fiume, Corrado Busi, Alessandro Mattioli
  • Patent number: 4581371
    Abstract: The administration by oral route of a composition comprising arginine pyrrolidone carboxylate and lysine pyrrolidone carboxylate at a dose of 150 to 200 mg/kg of body weight has immunomodulating activity capable of restoring depressed immunodefenses.
    Type: Grant
    Filed: March 18, 1983
    Date of Patent: April 8, 1986
    Assignee: Laboratori Baldacci S.p.A.
    Inventor: Massimo Baldacci
  • Patent number: 4313952
    Abstract: The treatment of patients suffering from acute alcoholic intoxication with pyridoxine 5-oxo-2-pyrrolidon-carboxylate permits the symptomatology of the psychomotor excitation and aggression to be readily and essentially completely solved.
    Type: Grant
    Filed: December 8, 1980
    Date of Patent: February 2, 1982
    Inventor: Massimo Baldacci